Market Research Report: Global Antimicrobial Susceptibility Testing (AST) Instrumentation Market
Report Overview
This comprehensive report provides a strategic analysis of the global Antimicrobial Susceptibility Testing (AST) Instrumentation market, covering market status, size, forecast, competitive landscape, and key insights for the period 2025 to 2036. AST instrumentation is critical for determining the sensitivity of pathogenic microorganisms to specific antimicrobial agents, guiding effective therapy and combating antimicrobial resistance (AMR).
Executive Summary
The global Antimicrobial Susceptibility Testing (AST) Instrumentation market is valued at an estimated USD XX billion in 2025 and is projected to reach USD YY billion by 2036, growing at a compound annual growth rate (CAGR) of ZZ% during the forecast period (2026-2036). This robust growth is driven by the escalating global threat of antimicrobial resistance (AMR), rising incidence of infectious diseases, stringent regulatory requirements for antibiotic stewardship, and technological advancements enabling faster, more accurate results.
Market Segmentation Analysis
1. By Product Type & Technology:
-
Automated AST Systems:
-
Automated Broth Microdilution Systems: High-throughput systems offering MIC (Minimum Inhibitory Concentration) results. The premium segment.
-
Automated Disk Diffusion Readers: Digital imaging systems that read and interpret zone diameters from agar plates.
-
-
Manual & Semi-Automated Products:
-
Susceptibility Testing Disks & Strips: Manual disk diffusion (Kirby-Bauer), Etest strips, and MIC gradient strips.
-
Culture Media & Prepared Plates: Mueller-Hinton agar, chromogenic media, and pre-poured AST panels.
-
-
Rapid AST Technologies:
-
PCR & Molecular-Based Systems: Detect resistance genes directly from specimens within hours.
-
Mass Spectrometry (MALDI-TOF) Assisted AST: Rapid identification with growing AST applications.
-
Microfluidic & Nanotechnology-based Devices: Emerging point-of-care and rapid phenotypic testing.
-
2. By Application:
-
Clinical Diagnostics (Largest Segment): For guiding patient therapy in hospitals, clinics, and diagnostic labs. Includes bloodstream infections, UTIs, respiratory infections, etc.
-
Drug Discovery & Development: For screening novel antimicrobial compounds and determining their spectrum of activity.
-
Epidemiology & Surveillance: Public health labs tracking resistance patterns (e.g., CDC, WHO GLASS).
-
Food & Agriculture Testing: For monitoring antibiotic residues and resistant pathogens in the food chain.
3. By End User:
-
Hospital & Reference Laboratories: Major end-users, especially large hospital networks with central microbiology labs.
-
Academic & Research Institutes
-
Contract Research Organizations (CROs)
-
Pharmaceutical & Biotechnology Companies
-
Public Health & Government Laboratories
4. By Pathogen Type:
-
Bacterial AST (Dominant)
-
Fungal AST (Growing segment with increasing antifungal resistance)
Regional Analysis
-
North America: The largest market, led by the U.S. Stringent regulatory guidelines from CDC and CMS promoting antibiotic stewardship, high healthcare expenditure, and early adoption of automated and rapid technologies drive dominance.
-
Europe: A major market with strong AMR surveillance programs and regulations (EUCAST guidelines). Germany, France, the UK, and Italy are key contributors.
-
Asia-Pacific: The fastest-growing region, fueled by high infectious disease burden, rising healthcare investments, increasing awareness of AMR, and growing local manufacturing in China, India, and Japan.
-
Latin America: Emerging market with Brazil and Mexico showing significant growth due to improving diagnostic infrastructure.
-
Middle East & Africa: Nascent market with growth opportunities in GCC nations (Saudi Arabia, UAE) and South Africa, driven by hospital modernization and AMR initiatives.
Competitive Landscape & Key Players
The market is consolidated with leading life science and diagnostic companies, alongside specialized microbiology firms.
-
bioMérieux SA (VITEK 2, VITEK MS, ETEST)
-
Becton, Dickinson and Company (BD) (BD Phoenix, BD Kiestra)
-
Thermo Fisher Scientific Inc. (Sensitive, Oxoid products)
-
Danaher Corporation (Beckman Coulter, Cepheid for molecular AST)
-
Merck KGaA (MilliporeSigma - culture media, reagents)
-
Bio-Rad Laboratories, Inc.
-
Accelerate Diagnostics, Inc. (Accelerate Pheno system - rapid AST)
-
Roche Diagnostics (Molecular diagnostics for resistance detection)
-
Liofilchem S.r.l. (MIC Test Strips)
-
Rosco Diagnostica A/S
-
Alifax Holding S.p.A. (Rapid methods for bacteriology)
-
Other Notable: HiMedia Laboratories, Creative Diagnostics, MERLIN Diagnostika GmbH, Synbiosis, Bioanalyse, Zhuhai DL Biotech.
Strategic Analysis Frameworks
Porter’s Five Forces Analysis
-
Competitive Rivalry: High. Intense competition among top players based on technological innovation (speed, automation, accuracy), test menu breadth, integration with lab informatics (LIS), and price. Competition exists between automated phenotypic, rapid phenotypic, and molecular methods.
-
Bargaining Power of Suppliers: Low to Moderate. Suppliers of raw materials (agar, antimicrobials, plastic components) are numerous. However, suppliers of proprietary reagents and consumables for closed-system instruments have higher power.
-
Bargaining Power of Buyers: High. Buyers are large hospital networks and national health systems with significant purchasing power. They often negotiate bundled contracts for instruments and consumables.
-
Threat of New Entrants: Moderate. High barriers include stringent regulatory approvals (FDA, CE-IVDR), need for extensive clinical validation, and established relationships in clinical labs. However, startups with disruptive rapid AST technologies can enter.
-
Threat of Substitutes: Low-Moderate. The core need for AST has no substitute. However, different technological approaches (e.g., rapid phenotypic vs. traditional automated vs. molecular) compete as substitutes for each other.
SWOT Analysis
-
Strengths: Critical role in clinical decision-making and public health; strong alignment with global AMR containment efforts; continuous technological evolution; recurring revenue from consumables.
-
Weaknesses: High cost of automated systems; lengthy turnaround time for traditional methods (18-24 hrs); complexity of interpreting results requiring skilled microbiologists.
-
Opportunities: Explosive growth in rapid AST technologies (<8 hours); integration with AI for advanced interpretation and outbreak prediction; expansion in high-growth emerging markets; rising demand for fungal AST.
-
Threats: Reimbursement pressures on diagnostic testing; implementation of the EU IVDR increasing compliance costs; potential for disruptive, low-cost point-of-care technologies.
Trend Analysis
-
Paradigm Shift to Rapid AST: Accelerating adoption of technologies delivering results in hours rather than days to improve patient outcomes and antibiotic stewardship.
-
Direct-from-Specimen Testing: Development of systems that perform AST directly from positive blood cultures or other clinical samples, bypassing the need for subculture.
-
Digitalization & AI Integration: Use of digital imaging, machine learning algorithms for zone reading, and software that links AST results with patient data to recommend optimal therapy.
-
Combatting Multi-Drug Resistant (MDR) Organisms: Expansion of test menus to include newer antibiotics and detect complex resistance mechanisms (e.g., ESBL, carbapenemase).
-
Workflow Automation & Consolidation: Integration of AST systems with automated specimen processing, ID systems, and lab informatics for seamless workflow.
Market Drivers & Challenges
-
Drivers:
-
Rising global prevalence of antimicrobial-resistant infections.
-
Increasing implementation of antimicrobial stewardship programs (ASPs) mandating rapid, accurate AST.
-
Growing number of complex surgical procedures and immunocompromised patients at risk of infection.
-
Technological advancements reducing turnaround time and improving ease-of-use.
-
-
Challenges:
-
High Instrumentation Cost: Limiting adoption in resource-constrained settings.
-
Shortage of Skilled Microbiology Technologists: To operate and interpret results from advanced systems.
-
Evolving and Complex Resistance Mechanisms: Requiring continuous test menu updates and method validation.
-
Regulatory Stringency: Particularly the new EU IVDR, increasing the burden for market entry and maintenance.
-
Value Chain Analysis
-
R&D & Technology Development: Development of novel detection chemistries, microfluidics, imaging software, and assay formulations.
-
Manufacturing & Production: Production of instruments, specialized culture media, antimicrobial disks/strips, and reagents under GMP conditions.
-
Regulatory Affairs & Clinical Validation: Extensive studies to correlate new methods with reference standards (CLSI, EUCAST) for regulatory clearance.
-
Marketing, Sales & Distribution: Through direct sales forces and specialized distributors targeting clinical microbiology labs.
-
Installation, Training & Support: Critical post-sale phase involving installation qualification (IQ), operational qualification (OQ), and comprehensive user training.
-
Consumable Sales & Ongoing Service: Recurring revenue stream from proprietary panels, plates, and reagents, along with service contracts.
-
End-Use & Data Reporting: Generation of patient reports that directly influence antibiotic prescribing, completing the stewardship loop.
Quick Recommendations for Stakeholders
-
For Instrument Manufacturers: Prioritize R&D in rapid, direct-from-specimen phenotypic technologies to address the critical need for faster results. Develop scalable solutions, from high-throughput hospital systems to compact devices for smaller labs. Ensure robust data connectivity (HL7, LIS interfacing) and compliance with evolving IVDR regulations.
-
For Clinical Laboratories & Hospitals: Evaluate AST systems based on total cost per result, inclusive of labor, consumables, and clinical impact (shorter length of stay). Invest in rapid AST technologies for critical areas like sepsis to demonstrate value in stewardship. Advocate for adequate reimbursement for rapid diagnostic tests.
-
For Public Health Authorities: Promote standardization of AST methods and data reporting to facilitate global AMR surveillance. Support funding and training for AST capacity building in low-resource settings.
-
For New Entrants: Focus on disruptive technology addressing a key bottleneck: speed, cost, or simplicity. Consider partnerships with larger companies for distribution and regulatory support. Target niche applications initially, such as specific high-threat pathogens (e.g., Candida auris, carbapenem-resistant organisms).
-
For Investors: Target companies with strong IP in rapid phenotypic AST, a clear path to regulatory approval, and a commercial strategy that addresses both high-complexity labs and the community hospital market. The convergence of microbiology, microfluidics, and AI for AST presents a high-growth opportunity.
Table of Contents
Global Antimicrobial Susceptibility Testing Instrument Market Research Report 2026
1 Industry Overview of Antimicrobial Susceptibility Testing Instrument
1.1 Definition and Specifications of Antimicrobial Susceptibility Testing Instrument
1.1.1 Definition of Antimicrobial Susceptibility Testing Instrument
1.1.2 Specifications of Antimicrobial Susceptibility Testing Instrument
1.2 Classification of Antimicrobial Susceptibility Testing Instrument
1.2.1 Automated Laboratory Instruments
1.2.2 Manual Antimicrobial Susceptibility Testing Products
1.2.3 Susceptibility Testing Disks
1.2.4 MIC strips
1.2.5 Others
1.3 Applications of Antimicrobial Susceptibility Testing Instrument
1.3.1 Clinical Diagnostics
1.3.2 Drug Discovery and Development
1.3.3 Epidemiology
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Antimicrobial Susceptibility Testing Instrument
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antimicrobial Susceptibility Testing Instrument
2.3 Manufacturing Process Analysis of Antimicrobial Susceptibility Testing Instrument
2.4 Industry Chain Structure of Antimicrobial Susceptibility Testing Instrument
3 Technical Data and Manufacturing Plants Analysis of Antimicrobial Susceptibility Testing Instrument
3.1 Capacity and Commercial Production Date of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
3.3 R&D Status and Technology Source of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
4 Global Antimicrobial Susceptibility Testing Instrument Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Antimicrobial Susceptibility Testing Instrument Capacity and Growth Rate Analysis
4.2.2 Antimicrobial Susceptibility Testing Instrument Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Antimicrobial Susceptibility Testing Instrument Sales and Growth Rate Analysis
4.3.2 Antimicrobial Susceptibility Testing Instrument Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Antimicrobial Susceptibility Testing Instrument Sales Price
4.4.2 Antimicrobial Susceptibility Testing Instrument Sales Price Analysis (Company Segment)
5 Antimicrobial Susceptibility Testing Instrument Regional Market Analysis
5.1 North America Antimicrobial Susceptibility Testing Instrument Market Analysis
5.1.1 North America Antimicrobial Susceptibility Testing Instrument Market Overview
5.1.2 North America E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.1.4 North America Antimicrobial Susceptibility Testing Instrument Market Share Analysis
5.2 Europe Antimicrobial Susceptibility Testing Instrument Market Analysis
5.2.1 Europe Antimicrobial Susceptibility Testing Instrument Market Overview
5.2.2 Europe E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.2.4 Europe Antimicrobial Susceptibility Testing Instrument Market Share Analysis
5.3 China Antimicrobial Susceptibility Testing Instrument Market Analysis
5.3.1 China Antimicrobial Susceptibility Testing Instrument Market Overview
5.3.2 China E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.3.4 China Antimicrobial Susceptibility Testing Instrument Market Share Analysis
5.4 Japan Antimicrobial Susceptibility Testing Instrument Market Analysis
5.4.1 Japan Antimicrobial Susceptibility Testing Instrument Market Overview
5.4.2 Japan E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.4.4 Japan Antimicrobial Susceptibility Testing Instrument Market Share Analysis
5.5 Southeast Asia Antimicrobial Susceptibility Testing Instrument Market Analysis
5.5.1 Southeast Asia Antimicrobial Susceptibility Testing Instrument Market Overview
5.5.2 Southeast Asia E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.5.4 Southeast Asia Antimicrobial Susceptibility Testing Instrument Market Share Analysis
5.6 India Antimicrobial Susceptibility Testing Instrument Market Analysis
5.6.1 India Antimicrobial Susceptibility Testing Instrument Market Overview
5.6.2 India E Antimicrobial Susceptibility Testing Instrument Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Antimicrobial Susceptibility Testing Instrument Sales Price Analysis
5.6.4 India Antimicrobial Susceptibility Testing Instrument Market Share Analysis
6 Global E Antimicrobial Susceptibility Testing Instrument Segment Market Analysis (by Type)
6.1 Global E Antimicrobial Susceptibility Testing Instrument Sales by Type
6.2 Different Types of Antimicrobial Susceptibility Testing Instrument Product Interview Price Analysis
6.3 Different Types of Antimicrobial Susceptibility Testing Instrument Product Driving Factors Analysis
6.3.1 Automated Laboratory Instruments Growth Driving Factor Analysis
6.3.2 Manual Antimicrobial Susceptibility Testing Products Growth Driving Factor Analysis
6.3.3 Susceptibility Testing Disks Growth Driving Factor Analysis
6.3.4 MIC strips Growth Driving Factor Analysis
6.3.5 Others Growth Driving Factor Analysis
7 Global E Antimicrobial Susceptibility Testing Instrument Segment Market Analysis (by Application)
7.1 Global E Antimicrobial Susceptibility Testing Instrument Consumption by Application
7.2 Different Application of Antimicrobial Susceptibility Testing Instrument Product Interview Price Analysis
7.3 Different Application of Antimicrobial Susceptibility Testing Instrument Product Driving Factors Analysis
7.3.1 Clinical Diagnostics of Antimicrobial Susceptibility Testing Instrument Growth Driving Factor Analysis
7.3.2 Drug Discovery and Development of Antimicrobial Susceptibility Testing Instrument Growth Driving Factor Analysis
7.3.3 Epidemiology of Antimicrobial Susceptibility Testing Instrument Growth Driving Factor Analysis
7.3.4 Others of Antimicrobial Susceptibility Testing Instrument Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Antimicrobial Susceptibility Testing Instrument
8.1 bioMerieux (France)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 bioMerieux (France) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 bioMerieux (France) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.2 Danaher (US)
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Danaher (US) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Danaher (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.3 BD (US)
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 BD (US) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 BD (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.4 Thermo Fisher (US)
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Thermo Fisher (US) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Thermo Fisher (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.5 Bio-Rad (US)
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Bio-Rad (US) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bio-Rad (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.6 Hi-Media (India)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Hi-Media (India) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Hi-Media (India) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.7 MERLIN (Germany)
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 MERLIN (Germany) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 MERLIN (Germany) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.8 Liofilchem (Italy)
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Liofilchem (Italy) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Liofilchem (Italy) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.9 Accelerate (US)
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Accelerate (US) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Accelerate (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.10 Alifax (Italy)
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Alifax (Italy) Antimicrobial Susceptibility Testing Instrument Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Alifax (Italy) Antimicrobial Susceptibility Testing Instrument Business Region Distribution Analysis
8.11 Creative Diagnostics (US)
8.12 Merck (Germany)
8.13 Synbiosis (UK)
8.14 Bioanalyse (Turkey)
8.15 Zhuhai DL Biotech (China)
9 Development Trend of Analysis of Antimicrobial Susceptibility Testing Instrument Market
9.1 Global Antimicrobial Susceptibility Testing Instrument Market Trend Analysis
9.1.1 Global 2018-2025 Antimicrobial Susceptibility Testing Instrument Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Antimicrobial Susceptibility Testing Instrument Sales Price Forecast
9.2 Antimicrobial Susceptibility Testing Instrument Regional Market Trend
9.2.1 North America 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.2.2 Europe 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.2.3 China 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.2.4 Japan 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.2.6 India 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Forecast
9.3 Antimicrobial Susceptibility Testing Instrument Market Trend (Product Type)
9.4 Antimicrobial Susceptibility Testing Instrument Market Trend (Application)
10 Antimicrobial Susceptibility Testing Instrument Marketing Type Analysis
10.1 Antimicrobial Susceptibility Testing Instrument Regional Marketing Type Analysis
10.2 Antimicrobial Susceptibility Testing Instrument International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antimicrobial Susceptibility Testing Instrument by Region
10.4 Antimicrobial Susceptibility Testing Instrument Supply Chain Analysis
11 Consumers Analysis of Antimicrobial Susceptibility Testing Instrument
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Antimicrobial Susceptibility Testing Instrument Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Antimicrobial Susceptibility Testing Instrument
Table Product Specifications of Antimicrobial Susceptibility Testing Instrument
Table Classification of Antimicrobial Susceptibility Testing Instrument
Figure Global Production Market Share of Antimicrobial Susceptibility Testing Instrument by Type in
Figure Automated Laboratory Instruments Picture
Table Major Manufacturers of Automated Laboratory Instruments
Figure Manual Antimicrobial Susceptibility Testing Products Picture
Table Major Manufacturers of Manual Antimicrobial Susceptibility Testing Products
Figure Susceptibility Testing Disks Picture
Table Major Manufacturers of Susceptibility Testing Disks
Figure MIC strips Picture
Table Major Manufacturers of MIC strips
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Antimicrobial Susceptibility Testing Instrument
Figure Global Consumption Volume Market Share of Antimicrobial Susceptibility Testing Instrument by Application in
Figure Clinical Diagnostics Examples
Table Major Consumers in Clinical Diagnostics
Figure Drug Discovery and Development Examples
Table Major Consumers in Drug Discovery and Development
Figure Epidemiology Examples
Table Major Consumers in Epidemiology
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Antimicrobial Susceptibility Testing Instrument by Regions
Figure North America Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Figure Europe Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Figure China Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Figure Japan Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Figure Southeast Asia Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Figure India Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) (2013-2025)
Table Antimicrobial Susceptibility Testing Instrument Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antimicrobial Susceptibility Testing Instrument in
Figure Manufacturing Process Analysis of Antimicrobial Susceptibility Testing Instrument
Figure Industry Chain Structure of Antimicrobial Susceptibility Testing Instrument
Table Capacity and Commercial Production Date of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
Table Manufacturing Plants Distribution of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
Table R&D Status and Technology Source of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
Table Raw Materials Sources Analysis of Global Antimicrobial Susceptibility Testing Instrument Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Antimicrobial Susceptibility Testing Instrument E
Figure Global E Antimicrobial Susceptibility Testing Instrument Market Size (Volume) and Growth Rate
Figure Global E Antimicrobial Susceptibility Testing Instrument Market Size (Value) and Growth Rate
Table E Global Antimicrobial Susceptibility Testing Instrument Capacity and Growth Rate
Table Global Antimicrobial Susceptibility Testing Instrument Capacity (K Units) List (Company Segment)
Table E Global Antimicrobial Susceptibility Testing Instrument Sales (K Units) and Growth Rate
Table Global Antimicrobial Susceptibility Testing Instrument Sales (K Units) List (Company Segment)
Table E Global Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Table Global Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure North America E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure North America Antimicrobial Susceptibility Testing Instrument Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure Europe E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure Europe Antimicrobial Susceptibility Testing Instrument Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure China E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure China Antimicrobial Susceptibility Testing Instrument Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure Japan E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure Japan Antimicrobial Susceptibility Testing Instrument Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure Southeast Asia E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure Southeast Asia Antimicrobial Susceptibility Testing Instrument Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Antimicrobial Susceptibility Testing Instrument E
Figure India E Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit)
Figure India Antimicrobial Susceptibility Testing Instrument Sales Market Share
Table Global E Antimicrobial Susceptibility Testing Instrument Sales (K Units) by Type
Table Different Types Antimicrobial Susceptibility Testing Instrument Product Interview Price
Table Global E Antimicrobial Susceptibility Testing Instrument Sales (K Units) by Application
Table Different Application Antimicrobial Susceptibility Testing Instrument Product Interview Price
Table bioMerieux (France) Information List
Table Product Overview
Table bioMerieux (France) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure bioMerieux (France) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Danaher (US) Information List
Table Product Overview
Table Danaher (US) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Danaher (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table BD (US) Information List
Table Product Overview
Table BD (US) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure BD (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Thermo Fisher (US) Information List
Table Product Overview
Table Thermo Fisher (US) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Thermo Fisher (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Bio-Rad (US) Information List
Table Product Overview
Table Bio-Rad (US) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Bio-Rad (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Hi-Media (India) Information List
Table Product Overview
Table Hi-Media (India) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Hi-Media (India) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table MERLIN (Germany) Information List
Table Product Overview
Table MERLIN (Germany) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure MERLIN (Germany) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Liofilchem (Italy) Information List
Table Product Overview
Table Liofilchem (Italy) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Liofilchem (Italy) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Accelerate (US) Information List
Table Product Overview
Table Accelerate (US) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Accelerate (US) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Alifax (Italy) Information List
Table Product Overview
Table Alifax (Italy) Antimicrobial Susceptibility Testing Instrument Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Alifax (Italy) Antimicrobial Susceptibility Testing Instrument Business Region Distribution
Table Creative Diagnostics (US) Information List
Table Merck (Germany) Information List
Table Synbiosis (UK) Information List
Table Bioanalyse (Turkey) Information List
Table Zhuhai DL Biotech (China) Information List
Figure Global 2018-2025 Antimicrobial Susceptibility Testing Instrument Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Antimicrobial Susceptibility Testing Instrument Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Antimicrobial Susceptibility Testing Instrument Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Antimicrobial Susceptibility Testing Instrument Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Antimicrobial Susceptibility Testing Instrument by Type 2018-2025
Table Global Consumption Volume (K Units) of Antimicrobial Susceptibility Testing Instrument by Application 2018-2025
Table Traders or Distributors with Contact Information of Antimicrobial Susceptibility Testing Instrument by Region
Market Segmentation Analysis
1. By Product Type & Technology:
-
Automated AST Systems:
-
Automated Broth Microdilution Systems: High-throughput systems offering MIC (Minimum Inhibitory Concentration) results. The premium segment.
-
Automated Disk Diffusion Readers: Digital imaging systems that read and interpret zone diameters from agar plates.
-
-
Manual & Semi-Automated Products:
-
Susceptibility Testing Disks & Strips: Manual disk diffusion (Kirby-Bauer), Etest strips, and MIC gradient strips.
-
Culture Media & Prepared Plates: Mueller-Hinton agar, chromogenic media, and pre-poured AST panels.
-
-
Rapid AST Technologies:
-
PCR & Molecular-Based Systems: Detect resistance genes directly from specimens within hours.
-
Mass Spectrometry (MALDI-TOF) Assisted AST: Rapid identification with growing AST applications.
-
Microfluidic & Nanotechnology-based Devices: Emerging point-of-care and rapid phenotypic testing.
-
2. By Application:
-
Clinical Diagnostics (Largest Segment): For guiding patient therapy in hospitals, clinics, and diagnostic labs. Includes bloodstream infections, UTIs, respiratory infections, etc.
-
Drug Discovery & Development: For screening novel antimicrobial compounds and determining their spectrum of activity.
-
Epidemiology & Surveillance: Public health labs tracking resistance patterns (e.g., CDC, WHO GLASS).
-
Food & Agriculture Testing: For monitoring antibiotic residues and resistant pathogens in the food chain.
3. By End User:
-
Hospital & Reference Laboratories: Major end-users, especially large hospital networks with central microbiology labs.
-
Academic & Research Institutes
-
Contract Research Organizations (CROs)
-
Pharmaceutical & Biotechnology Companies
-
Public Health & Government Laboratories
4. By Pathogen Type:
-
Bacterial AST (Dominant)
-
Fungal AST (Growing segment with increasing antifungal resistance)
